NASDAQ:TRAX | Cash Flow Statement | First Tracks Biotherapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2025-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$33.37M
2026-03-31-$50.48M$125,000.00-$32.56M$17,000.00$34.98M$7.85M
2025-06-30-$42.45M
2025-03-31-$47.2M$146,000.00-$45.01M$35,000.00$14.85M$5.72M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.